Biologics don't need long market exclusivity, FTC says

    loading  Checking for direct PDF access through Ovid

Abstract

But a generic biologics pathway bill that would grant at least 12 years of protection continues to attract co-sponsors.

Related Topics

    loading  Loading Related Articles